⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30952869 | 0.83 | — | — | |
| SCHEMBL333470 | 0.83 | — | — | |
| SCHEMBL321135 | 0.83 | — | — | |
| SCHEMBL29071584 | 0.81 | — | — | |
| SCHEMBL1763947 | 0.81 | — | — | |
| SCHEMBL1763948 | 0.81 | — | — | |
| SCHEMBL19968465 | 0.79 | — | — | |
| SCHEMBL29188620 | 0.79 | — | — | |
| SCHEMBL18924437 | 0.73 | — | — | |
| SCHEMBL2323063 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0693924-B1 | METHODS FOR (IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | AMERICAN BIOSCIENCE INC (US) | 2004-04-21 | — | — | EP | disclosed |
| US-5665383-A | CROSSLINKING AND SULFIDING BIOCOMPATIBLE MATERIAL | VIVORX PHARMACEUTICALS, INC. (US) | 1997-09-09 | — | — | US | disclosed |
| EP-0693924-A4 | METHODS FOR -i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS INC (US) | 1997-08-06 | — | — | EP | disclosed |
| US-5650156-A | ENCAPSULATION OF DRUGS, MICROPARTICLES, MICROEMULSIONS, SHELL CROSSLINKED BY DISULFIDE BONDS | VIVORX PHARMACEUTICALS, INC. (US) | 1997-07-22 | — | — | US | disclosed |
| US-5639473-A | SUBJECTING AQUEOUS MEDIUM CONTAINING BIOCOMPATIBLE MATERIAL CAPABLE OF BEING CROSSLINKED BY DISULFIDE BONDS AND NUCLEIC ACID CONSTRUCT TO HIGH INTENSITY ULTRASOUND WAVES | VIVORX PHARMACEUTICALS, INC. (US) | 1997-06-17 | — | — | US | disclosed |
| US-5635207-A | SUBJECTING AQUEOUS MEDIUM CONTAINING OXYGEN BINDING PROTEIN TO HIGH INTENSITY ULTRASOUND CONDITIONS TO PROMOTE CROSSLINKING AND FORM POLYMERIC SHELL OF SPECIFIED SIZE | VIVORX PHARMACEUTICALS, INC. (US) | 1997-06-03 | — | — | US | disclosed |
| US-5512268-A | CONTRAST AGENTS ENCAPSULATED IN BIOCOMPATIBLE POLYMER SHELL CROSSLINKED WITH DISULFIDE LIKAGE | VIVORX PHARMACEUTICALS, INC. (US) | 1996-04-30 | — | — | US | disclosed |
| US-5508021-A | BIOCOMPATIBLE CROSSLINKED POLYMER CONTAINING IMAGING AGENT | VIVORX PHARMACEUTICALS, INC. (US) | 1996-04-16 | — | — | US | disclosed |
| US-5505932-A | CONTAINING CONTRAST AGENT | VIVORX PHARMACEUTICALS, INC. (US) | 1996-04-09 | — | — | US | disclosed |
| US-5498421-A | IN A POLYMERIC SHELL CONTAINING SULFHYDRYL AND/OR DISULFIDE GROUPS | VIVORX PHARMACEUTICALS, INC. (US) | 1996-03-12 | — | — | US | disclosed |
| EP-0693924-A1 | METHODS FOR $i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS, INC. (US) | 1996-01-31 | — | — | EP | disclosed |
| US-5362478-A | Shell comprising biocompatible naturally occurring polymer which is crosslinked by disulfide bonds and which, before crosslinking, has covalently attached sulfhydryl or disulfide groups | VIVORX PHARMACEUTICALS, INC. (US) | 1994-11-08 | — | — | US | disclosed |
| WO-1994018954-A1 | METHODS FOR IN VIVO DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR | VIVORX PHARMACEUTICALS, INC. (US) | 1994-09-01 | — | — | WO | disclosed |